Accordingly, PREX2 is widely considered an oncogene due to its promotion of tumor proliferation, migration, and invasion in numerous neoplasms (i.e., glioma, melanoma, and breast, ovarian, prostatic, and pancreatic cancers) when mutated or overexpressed [68,69,70,71]. The gene discussed is PREX2; the disease is neoplasm.